| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000263244.1 |
AKT inhibitor VIII |
Bladder urothelial carcinoma |
0.006079177 |
Resistant |
| ENSG00000263244.1 |
AKT inhibitor VIII |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.029465832 |
Sensitive |
| ENSG00000263244.1 |
AKT inhibitor VIII |
Sarcoma |
0.016676331 |
Sensitive |
